http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-S61145160-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_324beb8b942a3a6ed1f1f576bcd76c45
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C323-56
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C67-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07B53-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C313-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07B31-00
filingDate 1984-12-20-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_48e24e8158f4dec3bb5e2525faa5ba18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e8768ac8c527b4b902e97fc2fc380f18
publicationDate 1986-07-02-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber JP-S61145160-A
titleOfInvention Production of optically active propionic acid derivative
abstract NEW MATERIAL:(+)-(2R*,3R*)-3-(2-aminophenylthio)-2-hydrox-y-3-(4-met-hoxy- phenyl)propionic acid derivative of formula I (R is H or 1W4C lower alkyl). n USE: An intermediate of filtiazem hydrochloride useful as a coronary vasodilator. n PREPARATION: The compound of formula I can be prepared according to the reaction formula, by (1) reacting the compound of formula III (M is alkali metal) with a mineral acid salt of an optically active organic amine, (2) decomposing the resultant diastereomer salt to the compound of formula IV (A 1 ⊕ is conjugated acid of organic base) taking advantage of the solubility difference in a solvent, (3) treating the compound with a base (e.g. alkali metal alkoxide, etc.), (4) esterifying the resultant compound of formula V (A 2 is alkali metal) to the compound of formula VI, (5) reacting the compound of formula VI with 2-aminothiophenol, and if necessary, (6) hydrolyzing the product. n COPYRIGHT: (C)1986,JPO&Japio
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0342902-A3
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5296618-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0342902-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5102998-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0338893-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5081277-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5008434-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0343474-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0342904-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5008411-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0343474-A3
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5013835-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-RE34935-E
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/AU-616517-B2
priorityDate 1984-12-20-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-S57136581-A
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226399125
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID425613610
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419557048
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID8713
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID313

Total number of triples: 35.